Palantir and dewpoint therapeutics announce strategic partnership

Denver & boston--(business wire)--palantir technologies inc. (nyse: pltr), a leading builder of operating systems for the modern enterprise, and dewpoint therapeutics (“dewpoint"), the leading biomolecular condensates company, today announced a partnership for palantir's foundry platform to help power dewpoint's efforts to discover treatments and cures for the most challenging diseases. palantir foundry will help to enable researchers at dewpoint to further their understanding of condensates bi
PLTR Ratings Summary
PLTR Quant Ranking